Determining optimal therapy--randomized trials in individual patients.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  New England Journal of Medicine

• Publication date

  1986-04-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJM198604033141406PMID 2936958
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Clinical Epidemiology: A Basic Science for Clinical Medicine

  1986cited by this paper
• Methodologic problems in clinical trials in heart failure.

  1985cited by this paper
• Crossover and self-controlled designs in clinical research.

  1984cited by this paper
• The lie that heals: the ethics of giving placebos.

  1982cited by this paper
• Heart failure in outpatients: a randomized trial of digoxin versus placebo.

  1982cited by this paper
• Effect of theophylline on gastroesophageal reflux in normal adults.

  1981cited by this paper
• Bias in analytic research.

  1979cited by this paper
• The two-period cross-over clinical trial.

  1979cited by this paper
• Single Subject Research: Strategies for Evaluating Change

  1978cited by this paper
• Clinical diagnosis and the clinical laboratory.

  1978cited by this paper
• Single Case Experimental Designs: Strategies for Studying Behavior Change

  1976cited by this paper
• Clinical biostatistics. II. Statistics versus science in design of experiments.

  1970cited by this paper
• Clinical biostatistics. II. Statistics versus science in design of experiments.

  1970cited by this paper

• Continuous outcome estimation in N-of-1 trials for accelerated decision-making.

  2026cites this paper
• Individual-centric N-of-1 trials: a case study assessing the effect of alcohol abstinence on mood levels

  2026cites this paper
• Induced forward-tilt training restoring ambulation from inability to stand in refractory post-stroke retropulsion: A single-case study.

  2026cites this paper
• Understanding Treatment Response Heterogeneity Using Crossover Randomized Controlled Trials: A Primer for Exercise and Nutrition Scientists.

  2025cites this paper
• When there is little or no research evidence: a clinical decision tool.

  2025cites this paper
• Blueprint for clinical N-of-1 strategies with off-label precision treatments in monogenic epilepsies

  2025cites this paper
• Evaluation of two easy-to-implement digital breathing interventions in the context of daily stress levels in a series of N-of-1 trials: results from the Anti-Stress Intervention Among Physicians (ASIP) study

  2025cites this paper
• Two‐Arm Crossover Randomized Controlled Trial Versus Meta‐Analysis of N‐of‐1 Studies: Comparison of Statistical Efficiency in Determining an Intervention Effect

  2025cites this paper
• 2024 John J Bonica Award Lecture: Less is More

  2025cites this paper
• Tumor-Agnostic Therapies in Practice: Challenges, Innovations, and Future Perspectives

  2025cites this paper
• Inter-Individual Variability of Acute Cardiovascular Responses to Low-Load Resistance Exercise with Different Methods of Blood Flow Restriction.

  2025cites this paper
• Protocol for a personalized (N-of-1) trial for testing the effects of a mind–body intervention on sleep duration in middle-aged women working in health care

  2024cites this paper
• Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus.

  2024cites this paper
• Design of clinical trials in integrative medicine: The issue of personalization

  2024cites this paper
• Navigating the uncommon: challenges in applying evidence-based medicine to rare diseases and the prospects of artificial intelligence solutions

  2024cites this paper
• Nature of the evidence base and approaches to guide nutrition interventions for individuals: a position paper from the Academy of Nutrition Sciences

  2024cites this paper
• A framework for N-of-1 trials of individualized gene-targeted therapies for genetic diseases

  2024cites this paper
• A methodological review of randomised n-of-1 trials

  2024cites this paper
• The development of a set of key points to aid clinicians and researchers in designing and conducting n-of-1 trials

  2024cites this paper
• N-of-1 Studies in an Era of Precision Medicine.

  2024cites this paper
• N‐of‐1 trials in epilepsy: A systematic review and lessons paving the way forward

  2024cites this paper
• Deucrictibant for angioedema due to acquired C1-inhibitor deficiency: a randomized-controlled trial.

  2024cites this paper
• Assessing the potential for precision medicine in body weight reduction with regard to type 2 diabetes mellitus therapies: A meta‐regression analysis of 120 randomized controlled trials

  2024cites this paper
• Feasibility Test of Personalized (N-of-1) Trials for Increasing Middle-Aged and Older Adults’ Physical Activity

  2024cites this paper
• Personalized (N-of-1) Clinical Trials for Inflammatory Bowel Disease: Opportunities and Challenges.

  2024cites this paper
• Effect of Advanced Footwear Technology Spikes on Sprint Acceleration: A Multiple N-of-1 Trial

  2024cites this paper
• Clinical therapeutic trials

  2023cites this paper
• Seeing through a glass darkly: Uncertainties about palliative care for patients with interstitial lung disease

  2023cites this paper
• N-of-1 Trials in Cancer Drug Development

  2023cites this paper
• Feasibility Test of Personalized (N-of-1) Trials for Increasing Middle-Aged and Older Adults’ Physical Activity

  2023cites this paper
• Protocol for randomized personalized trial for stress management compared to standard of care

  2023cites this paper
• How Electronic Medical Record Integration Can Support More Efficient Critical Care Clinical Trials.

  2023cites this paper
• Expresión numérica del curso clínico de la enfermedad. Manejo de datos

  2023cites this paper
• Nutrition-Related N-of-1 Studies Warrant Further Research to Provide Evidence for Dietitians to Practice Personalized (Precision) Medical Nutrition Therapy: A Systematic Review

  2023cites this paper
• Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations.

  2023cites this paper
• Commentary: Modeling the malleable mental health trajectory - a commentary on Oldehinkel and Ormel (2022).

  2023cites this paper
• Scientist practitioners in complementary medicine practice: A case study in an N-of-1 trial.

  2022cites this paper
• Assisting Walking in Patients with Chronic Respiratory Disease Using a Powered Exoskeleton: A Series of N-of-1 Trials.

  2022cites this paper
• The medical gap: intuition in medicine

  2022cites this paper
• Computer clinical decision support that automates personalized clinical care: a challenging but needed healthcare delivery strategy

  2022cites this paper
• Breaking new frontiers: Assessment and re-evaluation of clinical trial design for nutraceuticals

  2022cites this paper
• A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes

  2022cites this paper
• An R Shiny App for a Chronic Lower Back Pain Study, Personalized N-of-1 Trial

  2022cites this paper
• Testing Behavior Change Techniques to Increase Physical Activity in Middle-Aged and Older Adults: Protocol for a Randomized Personalized Trial Series

  2022cites this paper
• What possibly affects nighttime heart rate? Conclusions from N-of-1 observational data

  2022cites this paper
• Conduct and Implementation of Personalized Trials in Research and Practice

  2022cites this paper
• The reporting quality of N‐of‐1 trials and protocols still needs improvement

  2022cites this paper
• Multiple N-of-1 trials to investigate hypoxia therapy in Parkinson’s disease: study rationale and protocol

  2022cites this paper
• Model‐Twin Randomization (MoTR) for Estimating the Recurring Individual Treatment Effect

  2022cites this paper
• Personalized (N-of-1) Trials for Patient-Centered Treatments of Multimorbidity

  2022cites this paper
• N‐of‐1 trials to facilitate evidence‐based deprescribing: Rationale and case study

  2022cites this paper
• Single case designs for early phase behavioral translational research in health psychology.

  2021cites this paper
• Individualized therapy trials: navigating patient care, research goals and ethics

  2021cites this paper
• Single-Case Experimental Designs: Clinical Research and Practice

  2021cites this paper
• Status of N-of-1 Trials in Chronic Pain Management: A Narrative Review

  2021cites this paper
• Clinical Trials for Orthostatic Hypotension in Parkinson’s Disease and Other Synucleinopathies

  2021cites this paper
• Comparing the Bayesian Unknown Change-Point Model and Simulation Modeling Analysis to Analyze Single Case Experimental Designs

  2021cites this paper
• 4-Aminopyridine is a promising treatment option for patients with gain-of-function KCNA2-encephalopathy

  2021cites this paper
• N-of-1 Trials in Pediatric Oncology: From a Population-Based Approach to Personalized Medicine—A Review

  2021cites this paper
• StudyMe: a new mobile app for user-centric N-of-1 trials

  2021cites this paper
• Better health-related quality of life in kidney transplant patients compared to chronic kidney disease patients with similar renal function

  2021cites this paper
• Leveraging applied behavior analysis research and practice in the service of public health.

  2021cites this paper
• Racial and ethnic minority patient participation in N-of-1 trials: perspectives of healthcare providers and patients.

  2021cites this paper
• Alternative strategies in cardiac preclinical research and new clinical trial formats

  2021cites this paper
• The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs.

  2021cites this paper
• Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials

  2021cites this paper
• Establishment of an International Collaborative Network for N-of-1 Trials and Single-Case Designs

  2021cites this paper
• Current Advances in Clinical Trials for Rare Disease Populations: Spotlight on the Patient.

  2021cites this paper
• Experimental Designs to Optimize Treatments for Individuals: Personalized N-of-1 Trials.

  2021cites this paper
• Class IV studies, meta-analyses, meta-syntheses-Scope and limitations.

  2020cites this paper
• for Orthostatic in Parkinson’s and Other

  2020cites this paper
• Chapter 9. The Individual Relativity of Health and Disease: Personalized Medicine in the Light of Canguilhem’s Philosophy of Medicine

  2020cites this paper
• Enhancing Choice and Outcomes for Therapeutic Trials in Chronic Pain: N-of-1 + Imaging (+ i).

  2020cites this paper
• Clinical Trials for Neurogenic Orthostatic Hypotension: A Comprehensive Review of Endpoints, Pitfalls, and Challenges

  2020cites this paper
• How to choose your study design

  2020cites this paper
• Individual point-of-care trials: a new approach to incorporate patient's preferences into personalized pragmatic clinical trials.

  2020cites this paper
• Digital Twins and the Emerging Science of Self: Implications for Digital Health Experience Design and “Small” Data

  2020cites this paper
• Factors Associated With Trial Completion and Adherence in App-Based N-of-1 Trials: Protocol for a Randomized Trial Evaluating Study Duration, Notification Level, and Meaningful Engagement in the Brain Boost Study

  2020cites this paper
• [Participant-funded clinical trials on rare diseases].

  2020cites this paper
• Current Status of N-of-1 Trials for Herbal Medicine -Literature Review

  2020cites this paper
• Confirmation of Hypotheses in Clinical Medical Science

  2020cites this paper
• Studies of Microsurgical Skill-The Key Lies in the Design-Reply.

  2020cites this paper
• The Weight of Evidence Account Defended

  2020cites this paper
• Participant-funded clinical trials on rare diseases.

  2020cites this paper
• N-of-1 Clinical Trials.

  2019cites this paper
• Confounding obscures our view, effect modification is part of reality.

  2019cites this paper
• Effects of Sleep Deprivation on Blood Glucose, Food Cravings, and Affect in a Non-Diabetic: An N-of-1 Randomized Pilot Study

  2019cites this paper
• What counts as evidence? Swimming against the tide: Valuing both clinically informed experimentally controlled case series and randomized controlled trials in intervention research

  2019influential citation
• Acceptability and barriers to implementation of N-of-1 tests in Ethiopia - a qualitative study

  2019cites this paper
• Making the switch: From case studies to N-of-1 trials

  2019influential citation
• N-of-1 Trials as a Decision Support Tool in Clinical Practice: A Protocol for a Systematic Literature Review and Narrative Synthesis

  2019cites this paper
• The Philosophy of Evidence-Based Principles and Practice in Nutrition

  2019cites this paper
• Musicians' Health Problems

  2019cites this paper
• N-of-1 Trials in Hypertension Are Feasible, but Are They Worthwhile?

  2019cites this paper
• The impact of treatment and other clinical and community health interventions: A ‘does it work?’ evaluation

  2019cites this paper
• Some t-tests for N-of-1 trials with serial correlation

  2019cites this paper
• Comparison of Aggregated N-of-1 Trials with Parallel and Crossover Randomized Controlled Trials Using Simulation Studies

  2019cites this paper
• CONSORT extension for reporting N-of-1 trials for traditional Chinese medicine (CENT for TCM) : Recommendations, explanation and elaboration.

  2019cites this paper
• Person-Centered Research: A novel approach to Randomized Controlled Trials

  2018cites this paper
• The Importance of Applying Evidence-Based Medicine in Clinical Practice

  2018cites this paper